尊龙凯时
About us
尊龙凯时:Our Values
尊龙凯时:Development Milestone
Products
尊龙凯时:Product List for API
尊龙凯时:Recommended API
尊龙凯时:Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
尊龙凯时:Contract Manufacturing
尊龙凯时:API and Pharmaceutical Intermediates
尊龙凯时:OTC and Generics
尊龙凯时:Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
尊龙凯时:Contact Us
About us
News
尊龙凯时:Investor Relation
Products
尊龙凯时:Contract Manufacturing
尊龙凯时:Contact Us
Investor Relation
Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
Overseas Regulatory Announcement
2021-12-22
Overseas Regulatory Announcement
2021-12-21
Clarification Announcement in Relation to Change of Book Closure Period And Reco
2021-12-16
Shandong Lukang Agreement
2021-12-15
Hualu Hengsheng Agreement
2021-12-15
China Shandong Agreement
2021-12-15
Writtten Consent of the Experts
2021-12-15
Letter From The Independent Financial Adviser
2021-12-15
Letter From The Independent Board Committee
2021-12-15
Reply Slip for the Class Meeting of H Shareholders
2021-12-15
<
...
21
22
23
24
25
26
27
...
>